Most Recent
Aristocrat docs still ‘floating around’ rival’s office, court told
Gaming giant Aristocrat Technologies told a court Wednesday that confidential material used by a designer to steal its poker machine idea may yet find its way into the launch version of its rival's machine, despite assurances to the contrary.
Bega ratchets up claims in peanut butter feud with Kraft
Bega Cheese has brought new allegations against Kraft in their dispute over who owns the rights to the signature Kraft peanut butter packaging in Australia.
Aristocrat wants to sue gaming rival for stealing poker machine idea
Gaming giant Aristocrat has commenced legal action against rival Ainsworth, claiming a “controversial” game designer used confidential information to develop a competing slot machine.
Roche asks court to stop launch of Novartis’ MabThera biosimilar
Drug giant F. Hoffman-La Roche asked the Federal Court Tuesday for an order barring the release of a generic version of its blockbuster cancer drug MabThera by a unit of Swiss rival Novartis, which it claims could lead to "tens of millions of dollars" in losses.
Kraft can’t sidestep Australian court’s arbitration stay ruling
A Federal Court judge has shot down Kraft's suggestion that his order blocking it from acting further in a US arbitration between it and Bega over peanut butter trade dress rights should only pertain to its claims and not Bega's cross-claim. 
Judge halts Kraft-Bega arbitration in US while Aussie case proceeds
A judge has granted Bega's request to halt US arbitration proceedings between the Australian food maker and Kraft over peanut butter trade dress rights until a related case in Federal Court is resolved.
Telstra, Vodafone settle Voxson infringement suit over GPS patent
Telstra and Vodafone have reached a mid-trial deal to end an infringement case alleging use of GPS technology by the telcos to track customer phones violates a 1994 patent.
Bayer pesticide patents invalidated after Syngenta challenge
The Australian Patent Office has invalidated two insecticide patents by Bayer on a challenge by rival Syngenta, with a delegate of the agency ruling the inventions' claims were obvious.